Application and Agreement to Participate in IREX IX

Application and Agreement to Participate in Iris Exchange IX

1. Who Should participate

1.1. Organizations ("Organizations") that develop iris matching software are eligible to participate.

1.2. Anonymous participation will not be permitted. This means that signatories to this document, Application and Agreement to Participate in Iris Exchange IX, acknowledge that they understand that the results

(see Section 2.4) of the test of the Submission will be published with attribution to their Organization.

2. How to Participate

2.1. In order to participate in IREX IX, an Organization must provide the information requested in Section 9

of this Agreement (see below) identifying the Responsible Party, and the Point of Contact. Organization

must also print and sign this Agreement, and send it to the location designated in Section 9.

2.1.1. The Responsible Party is an individual with the authority to commit the Organization to the terms

in this Agreement.

2.1.2. The Point of Contact is an individual within the Organization with detailed knowledge of the participating Submission.

2.1.3. The Responsible Party and POC may be the same person.

2.2. Upon receipt of the signed Agreement by NIST, the Organization will be classified as a “Participant” in

IREX IX. Applicants need only send one signed application; they do not need to send a new application

for each submitted library.

2.3. Participant shall provide submissions ("Submissions") as specified in Section of the IREX IX Concept,

Evaluation Plan, and API Specification ("Test Plan"). A Submission shall include all library files, configuration files, documentation, and all other files required by NIST and the Participant to validate and

execute the tests specified in the Test Plan.

2.4. The Submission need not be used in a production system or be commercially available. However, the

Submission must, at a minimum, be a stable implementation capable of conforming to the Test Plan

that NIST has published for IREX IX.

2.5. The Submission must be encrypted before transmitting to NIST. Instructions for submitting can be

found at http://biometrics.nist.gov/cs_links/iris/irex/NIST_biometrics_crypto2.pdf. Generic encryption

instructions can be found in the Image Group’s Encrypting Software for Transmission to NIST document

available at http://www.nist.gov/itl/iad/ig/encrypt.cfm. A box for the Participant’s public key fingerprint is

included on the Agreement. Submissions that are not signed with the public key fingerprint listed on

the Agreement will not be accepted.

2.6. Submissions must be compliant with the Test Plan, NIST test hardware, and NIST test software.

3. Points of Contact

3.1. The IREX IX Liaison is the U.S. Government point of contact for IREX IX.

3.2. All questions should be directed to the irex@nist.gov, which will be received by the IREX IX Liaison and

other IREX IX personnel.

4. Access to IREX IX Validation Samples

4.1. The IREX IX validation package is supplied to Participant to assist in preparing for IREX IX.

4.2. The iris samples in the IREX IX validation package are representative of the IREX IX test data only

in format. Image quality, collection device, and other characteristics may vary between the validation

samples and the test datasets.

5. Access to IREX IX Test Data

5.1. Participant will not have access to IREX IX Test Data.
Application and Agreement to Participate in IREX IX

6. Release of IREX IX Results

6.1. After the completion of IREX IX testing, the U.S. Government will publish all results obtained, along

with the Organization’s name on the IREX IX website.

6.2. Participant will be notified of the results via the Responsible Party and the Point of Contact provided on

the Agreement.

6.3. After the release of the IREX IX results, Participant may use the results for their own purposes.

Such results shall be accompanied by the following phtase: "Results shown from NIST do not constitute an endorsement of any particular system, produce, service, or company by the U.S. Government." Such results shall also be accompanied by the Internet address (URL) of the IREX IX website

(http://www.nist.gov/itl/iad/ig/irexix.cfm).

7. Additional Information

7.1. Any data obtained during IREX IX, as well as any documentation required by the U.S. Government

from the Participant (except the Submission), becomes the property of the U.S. Government. Participant will not acquire a proprietary interest in the data and/or submitted documentation. The data and

documentation will be treated as sensitive information and only be used for the purposes of NIST tests.

7.2. Participant agrees that they will not file any IREX IX-related claim against IREX IX sponsors, supporters, staff, contractors, or agency of the U.S. Government, or otherwise seek compensation for any

equipment, materials, supplies, information, travel, labor and/or other Participant-provided services.

7.3. The U.S. Government is not bound or obligated to follow any recommendations that may be submitted

by the Participant. The U.S. Government, or any individual agency, is not bound, nor is it obligated, in

any way to give any special consideration to Participant on future contracts.

7.4. By signing this Agreement, Participant acknowledge that they understand any test details and/or modifications that are provided in the IREX IX website supersede the information on this Agreement.

7.5. Participant may withdraw from IREX IX at any time before their Submission is received by NIST, without

their participation and withdrawal being documented on the IREX IX website.

7.6. NIST will use the Participant’s Submission only for NIST tests, and in the event errors are subsequently

found, to re-run prior tests and resolve those errors.

7.7. NIST agrees not to use the Participant’s Submission for the purposes other than indicated above,

without the express permission by the Participant.

8. Reminders

8.1. NIST must receive the signed Agreement and Submission no later than September 7th, 2016 for Phase

I participation, and January 7th, 2017 for Phase II participation (unless NIST extends these deadlines

on the IREX IX webpage).

8.2. NIST requests that applicants send an email to irex@nist.gov after they have sent their applications.

NIST will respond with a confirmation message upon receipt of the application.

8.3. See http://www.nist.gov/itl/iad/ig/irexix.cfm for the latest updates and information on IREX IX.

9. Application Submission

9.1. Please mail the completed and signed Agreement to:

IREX IX Test Liason (A214)

100 Bureau Drive

A214/Tech225/Stop 8940

NIST

Gaithersburg, MD 20899-8940

USA
Application and Agreement to Participate in IREX IX

Organization Name

Responsible Party

Full Name

Address (Line 1)

Address (Line 2)

Address (Line 3)

Phone Number Fax Number E-mail Address

Point of Contact Check if same as Responsible Party above: ⇤

Full Name

Address (Line 1)

Address (Line 2)

Address (Line 3)

Phone Number Fax Number E-mail Address

Participant must complete the box below per the instructions for transmission of encrypted content to NIST, as

defined at http://biometrics.nist.gov/cs_links/iris/irex/NIST_biometrics_crypto2.pdf. If preferred, Participant may fax

their public key fingerprint to the IREX IX Liaison at (301) 975-5287.

Public Key Fingerprint

Participant

NIST

A75C EECD EF65 3197 7E66 A960 67D0 4015 407A D929

With my signature, I hereby request consideration as a Participant in the Iris Exchange (IREX) IX Evaluation,

and I am authorizing my Organization to participate in IREX IX according to the rules and limitations listed in this

document.

With my signature, I also state that I have the authority to accept the terms stated in this Agreement.

Signature of Responsible Party Date